Butterfly Network to Present at the 44th Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact

(Neutral)

Rhea-AI Sentiment

(Positive)

Tags

12/18/2025 - 08:05 AM

NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)-- Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that it will participate in the 44th Annual J.P. Morgan Healthcare Conference taking place January 12-15, 2026 in San Francisco, California.

Joseph DeVivo, President, Chief Executive Officer & Chairman; John Doherty, Executive Vice President & Chief Financial Officer; and Megan Carlson, Senior Vice President – Accounting & Finance, Chief Accounting Officer will host investor meetings and the Company will present on Thursday, January 15, 2026 at 9:00 AM PST.

A webcast of the presentation will be posted on the Events & Presentations section of the Butterfly investor website, and be available for replay until February 15, 2026.

To schedule a meeting with Butterfly management, please reach out to the Company directly via the contacts below or request a one-on-one through your J.P. Morgan representative.

About Butterfly Network

Butterfly Network, Inc. (NYSE: BFLY) is a healthcare company driving a digital revolution in medical imaging with its proprietary Ultrasound-on-Chip™ semiconductor technology and ultrasound software solutions. In 2018, Butterfly launched the world’s first handheld, single-probe, whole-body ultrasound system, Butterfly iQ. The iQ+ followed in 2020, and the iQ3 in 2024, each with improved processing power and performance by leveraging Moore’s Law. The iQ3 earned Best Medical Technology at the 2024 Prix Galien USA Awards, a prestigious honor and one of the highest accolades in healthcare. Butterfly’s innovations have also been recognized by Fierce 50, TIME’s Best Inventions and Fast Company’s World Changing Ideas, among other achievements.

Butterfly combines advanced hardware, intelligent software, AI, services, and education to drive adoption of affordable, accessible imaging. Clinical publications demonstrate that its handheld ultrasound probes paired with Compass™ enterprise workflow software, can help hospital systems improve care workflows, reduce costs, and enhance provider economics. With a cloud-based solution that enables care anywhere through next-generation mobility, Butterfly aims to democratize healthcare by addressing critical global healthcare challenges. Butterfly devices are commercially available to trained healthcare practitioners in areas including, but not limited to, parts of Africa, Asia, Australia, Europe, the Middle East, North America and South America; to learn more about available countries, visit: https://www.butterflynetwork.com/choose-your-country.